News Announcement

Piramal Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 31st December 2025

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.